This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jun;8(6):297.

doi: 10.1038/nrgastro.2011.79.

Obesity: Potential value of combined treatment for the medical management of obesity

PMID: 21643024
DOI: 10.1038/nrgastro.2011.79

Comment

Obesity: Potential value of combined treatment for the medical management of obesity

Natalie J Wood. Nat Rev Gastroenterol Hepatol. 2011 Jun.

. 2011 Jun;8(6):297.

doi: 10.1038/nrgastro.2011.79.

Author

PMID: 21643024
DOI: 10.1038/nrgastro.2011.79

No abstract available

PubMed Disclaimer

Comment on

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Gadde KM, et al. Lancet. 2011 Apr 16;377(9774):1341-52. doi: 10.1016/S0140-6736(11)60205-5. Epub 2011 Apr 8. Lancet. 2011. PMID: 21481449 Clinical Trial.

References

1. Lancet. 2011 Apr 16;377(9774):1341-52 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.